Ro's CEO explains how the health company built its new AI agent

Ro CEO Zach Reitano sat down with Business Insider to talk about how the health company has changed over nine years. The headline says he also explains how Ro built its new AI agent. The interview was part of Business Insider's series The Long Play.

What was discussed

Ro began with direct-to-patient services. It is now described as a leading platform for GLP-1 care. GLP-1 drugs are a class of medicines widely used for diabetes and weight loss.

Reitano spoke with Business Insider legal correspondent Melia Robinson. They covered the business decisions behind each shift as patient needs and the healthcare market changed. They also covered how Ro is positioning itself for the next era of consumer health. Reitano shared what he has learned as a founder leading through quick and unrelenting change.

What is not known yet

The available text does not describe the AI agent. It does not say what the tool does, who can use it, or how it handles personal health information. No launch date or details about how it was built are included here.

Health apps are adding AI helpers more often. Anyone who uses one should ask what it does for them and how their health information is handled. The full interview may answer those questions.